December 30, 2025 09:15 ET | Source: Akari Therapeutics Plc TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) --…
December 24, 2025 13:05 ET | Source: ImmuCell Corporation PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:…
December 24, 2025 16:00 ET | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL…
DALLAS, Dec. 16, 2025 /PRNewswire/ -- The U.S. Start-up, DirectH2 Inc. led by Dr. Vivek V. Dhas, Chief Executive Officer,…
Iconic Pen Brand Partners with Hit Series to Bring Parisian Elegance to Every Written Word BANGALORE, India, Nov. 11, 2025…
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today released a letter to shareholders at the one-year milestone…
New York, Sept. 21, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), the world’s leading…
September 05, 2025 16:30 ET | Source: DIH Holding US, Inc. DIH Receives Notice for Continued Deficiency and Delist Letter…
July 11, 2025 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo:…